Search
Search Results
##search.searchResults.foundPlural##
-
Peripheral Red Blood Cell Split Chimerism as a Consequence of Intramedullary Selective Apoptosis of Recipient Red Blood Cells in a Case of Sickle Cell Disease
1670PDF: 1024HTML: 1886Untitled: 205Untitled: 189 -
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6988PDF: 3701HTML: 808 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4138Suppl. Files: 1184PDF: 1102Html: 242 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3787PDF: 1505HTML: 243 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5230PDF: 1353HTML: 2799Cover letter: 212 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2389PDF: 1680HTML: 354 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4508PDF: 1749HTML: 1111 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2308PDF: 921HTML: 2139 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1784PDF: 871HTML: 564 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2499PDF: 895HTML: 2502 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2640PDF: 892HTML: 17578Fig1 Caligaris: 193Fig.2 Caliga: 236 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2242PDF: 2074HTML: 203 -
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2214PDF: 1740HTML: 557 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1090PDF: 1196Suppl. Files: 576HTML: 94 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3188PDF: 1160HTML: 1589Untitled: 186Untitled: 182Untitled: 180 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2592PDF: 864HTML: 8969Efremov 1: 244Efremov 2: 208 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3765PDF: 1647HTML: 84 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3115PDF: 890HTML: 7219Kost Fig1: 202Kost Fig 2: 191Kost Fig3: 193Kost Fig 4: 205Kost Fig5: 203Kost fig 6: 189 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2902PDF: 1116HTML: 126 -
How I treat acute and persistent sickle cell pain
2016PDF: 1134HTML: 554 -
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2872PDF: 1162HTML: 11291 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3814PDF: 1618HTML: 680Figures . Eliassian: 235 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3641PDF: 2556HTML: 1526 -
IMMUNOLOGY OF TUBERCULOSIS
5499PDF: 2042HTML: 7346Untitled: 206 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3308PDF: 1482HTML: 5960Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3819PDF: 1618HTML: 8110Randi Fig: 194 -
SICKLE CELL ANAEMIA AND MALARIA
11643PDF: 7205HTML: 23979Figures Malaria and SCK: 233 -
-
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2633PDF: 819HTML: 5289 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2260PDF: 992HTML: 1933 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2337PDF: 1347HTML: 17138Bassan Fig.1: 154Bassan Fig.2: 174Bassan Fig.4: 146Fig.3: 215







